Akèy › Limfom Difize Gwo Selil B › North Dakota › Fargo

Etid klinik pou Limfom Difize Gwo Selil B nan Fargo, ND

4 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Fargo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Ap rekriteFaz 2

Essentia Health Cancer Center-South University Clinic, Fargo

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06649812

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Ap rekriteFaz 3

Sanford Health Roger Maris Cancer Center ( Site 0189), Fargo

Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06717347

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 1003), Fargo

6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Ap rekriteFaz 2

Sanford Broadway Medical Center, Fargo
Sanford Roger Maris Cancer Center, Fargo

Laj 18 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT05633615

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Fargo

Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.